{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:59:58Z","timestamp":1786118398470,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1097\/01.fjc.0000246149.92535.59","type":"journal-article","created":{"date-parts":[[2006,11,3]],"date-time":"2006-11-03T04:26:47Z","timestamp":1162528007000},"page":"166-172","source":"Crossref","is-referenced-by-count":4,"title":["Neurohumoral Changes in Patients With Left Ventricular Dysfunction Following Acute Myocardial Infarction and the Effect of Nitrate Therapy: A Randomized, Double-Blind, Placebo-Controlled Long-Term Study"],"prefix":"10.1097","volume":"48","author":[{"given":"Erik","family":"Tingberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Roijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Thilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"\u00d6hlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210208","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of Veterans Administration Cooperative Study.","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"R2-6-20210208","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-6-20210208","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1067\/mhj.2003.41","article-title":"Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.","volume":"145","author":"Tingberg","year":"2003","journal-title":"Am Heart J"},{"key":"R5-6-20210208","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0196-9781(97)00248-9","article-title":"Analytical extraction of regulatory peptides from rat lung tissue.","volume":"18","author":"Kraiczi","year":"1997","journal-title":"Peptides"},{"key":"R6-6-20210208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15321818208056990","article-title":"A new sensitive radioimmunoassay for plasma arginine vasopressin.","volume":"3","author":"Rooke","year":"1982","journal-title":"J Immunoassay"},{"key":"R7-6-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-4347(00)83003-0","article-title":"Determination of catecholamines in human plasma by high-performance liquid chromatography: Comparison between a new method with fluorescence detection and an established method with electrochemical detection.","volume":"487","author":"van der Hoorn","year":"1989","journal-title":"J Chromatogr"},{"key":"R8-6-20210208","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/jcem-54-2-423","article-title":"Measurement of plasma renin activity by a simple solid phase radioimmunoassay.","volume":"54","author":"Ikeda","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-6-20210208","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00365599.1992.11690449","article-title":"Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment.","volume":"26","author":"Hegbrant","year":"1992","journal-title":"Scand J Urol Nephrol"},{"key":"R11-6-20210208","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0735-1097(83)80234-4","article-title":"Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and patients with congestive heart failure.","volume":"2","author":"Olivari","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"R12-6-20210208","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-9149(85)91184-1","article-title":"The hemodynamic and hormonal effects of high dose transdermal nitroglycerin in patients with chronic congestive heart failure.","volume":"56","author":"Elkayam","year":"1985","journal-title":"Am J Cardiol"},{"key":"R13-6-20210208","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1993.201","article-title":"Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy.","volume":"54","author":"Shotan","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R14-6-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000006870","article-title":"Effects of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.","volume":"91","author":"Lewis","year":"1999","journal-title":"Cardiology"},{"issue":"Suppl 2","key":"R15-6-20210208","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/00005344-199106182-00022","article-title":"The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions.","volume":"18","author":"Hall","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"R17-6-20210208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.60.2.117","article-title":"Neuroendocrine activation after acute myocardial infarction.","volume":"60","author":"McAlpine","year":"1988","journal-title":"Br Heart J"},{"key":"R18-6-20210208","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"R19-6-20210208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1388-9842(01)00196-9","article-title":"Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.","volume":"4","author":"Persson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"R20-6-20210208","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"issue":"Suppl 1","key":"R21-6-20210208","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2165\/00003495-198500301-00011","article-title":"Effects of enalapril on clinical status, biochemistry, exercise performance and hemodynamics in heart failure.","volume":"30","author":"Webster","year":"1985","journal-title":"Drugs"},{"key":"R22-6-20210208","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans.","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"R23-6-20210208","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"R24-6-20210208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure.","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"R25-6-20210208","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1475-097X.1986.tb00789.x","article-title":"Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.","volume":"6","author":"Pernow","year":"1986","journal-title":"Clin Physiol"},{"key":"R26-6-20210208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-6147(87)90069-1","article-title":"Effects of neuropeptide Y on the cardiovascular system.","volume":"8","author":"Edvinsson","year":"1987","journal-title":"Trends Pharmac Sci"},{"key":"R27-6-20210208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/hrt.71.3.261","article-title":"Cardiac neuropeptide Y and noradrenalin balance in patients with congestive heart failure.","volume":"71","author":"Feng","year":"1994","journal-title":"Br Heart J"},{"key":"R28-6-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2362.1990.tb01796.x","article-title":"Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres.","volume":"20","author":"Edvinsson","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"R29-6-20210208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2796.1991.tb00452.x","article-title":"Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.","volume":"230","author":"Valdemarsson","year":"1991","journal-title":"J Intern Med"},{"key":"R30-6-20210208","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1139\/y95-152","article-title":"Clinical perspectives of calcitonin gene related peptide pharmacology.","volume":"73","author":"Feuerstein","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"R31-6-20210208","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/oxfordjournals.eurheartj.a060088","article-title":"Plasma calcitonin gene-related peptide decreases in chronic congestive heart failure.","volume":"13","author":"Taquet","year":"1992","journal-title":"Eur Heart J"},{"key":"R32-6-20210208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","article-title":"Vasoactive intestinal peptide: cardiovascular effects.","volume":"49","author":"Henning","year":"2001","journal-title":"Cardiovasc Res"},{"key":"R33-6-20210208","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1365-2265.2003.01913.x","article-title":"Vasoactive intestinal peptide (VIP): a new neuroendocrine marker of clinical progression in chronic heart failure?","volume":"59","author":"Lucia","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R34-6-20210208","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.","volume":"47","author":"Iwanaga","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R35-6-20210208","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijcard.2004.08.023","article-title":"Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.","volume":"101","author":"Davila","year":"2005","journal-title":"Int J Cardiol"},{"key":"R36-6-20210208","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"R37-6-20210208","first-page":"H866","article-title":"Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release.","volume":"257","author":"Pernow","year":"1989","journal-title":"Am J Physiol"},{"key":"R38-6-20210208","first-page":"339","article-title":"Neuroendocrine activation in acute myocardial infarction: state of the art and preliminary results on intestinal vasoactive peptide.","volume":"32","author":"Caiola","year":"1996","journal-title":"Ann Ist Super Sanita"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005344-200610000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:46:52Z","timestamp":1786031212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200610000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000246149.92535.59","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}